PL3727453T3 - Ciekła kompozycja jako nośnik - Google Patents
Ciekła kompozycja jako nośnikInfo
- Publication number
- PL3727453T3 PL3727453T3 PL18825704.2T PL18825704T PL3727453T3 PL 3727453 T3 PL3727453 T3 PL 3727453T3 PL 18825704 T PL18825704 T PL 18825704T PL 3727453 T3 PL3727453 T3 PL 3727453T3
- Authority
- PL
- Poland
- Prior art keywords
- carrier
- liquid composition
- composition
- liquid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/33—Fibroblasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/006—Biological staining of tissues in vivo, e.g. methylene blue or toluidine blue O administered in the buccal area to detect epithelial cancer cells, dyes used for delineating tissues during surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
- A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
- A61K49/0071—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form solution, solute
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/064—Saccharomycetales, e.g. baker's yeast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Biodiversity & Conservation Biology (AREA)
- Oncology (AREA)
- Optics & Photonics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17210119.8A EP3501496A1 (en) | 2017-12-22 | 2017-12-22 | Liquid delivery composition |
| PCT/EP2018/086424 WO2019122253A1 (en) | 2017-12-22 | 2018-12-20 | Liquid Delivery Composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3727453T3 true PL3727453T3 (pl) | 2025-07-07 |
Family
ID=60782071
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL18825704.2T PL3727453T3 (pl) | 2017-12-22 | 2018-12-20 | Ciekła kompozycja jako nośnik |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US12011483B2 (pl) |
| EP (3) | EP3501496A1 (pl) |
| JP (2) | JP7494116B2 (pl) |
| KR (2) | KR20200103012A (pl) |
| CN (1) | CN111511352A (pl) |
| BR (1) | BR112020012519A2 (pl) |
| CA (1) | CA3081633A1 (pl) |
| DK (1) | DK3727453T3 (pl) |
| ES (1) | ES3031471T3 (pl) |
| FI (1) | FI3727453T3 (pl) |
| MX (2) | MX2020006664A (pl) |
| PL (1) | PL3727453T3 (pl) |
| RU (1) | RU2020124103A (pl) |
| WO (1) | WO2019122253A1 (pl) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230210790A1 (en) * | 2020-06-02 | 2023-07-06 | The Johns Hopkins University | Gel for use in gastrointestinal endoscopy and endodermal, epidermal, and other mucosal uses |
| AU2021328260A1 (en) * | 2020-08-17 | 2023-03-09 | Humanwell Pharmaceutical US | Long acting in-situ forming/gelling compositions |
| WO2022043759A1 (en) * | 2020-08-31 | 2022-03-03 | PreveCeutical Medical Inc. | Cannabinoid formulations and methods of use |
| LU102338B1 (en) * | 2020-12-21 | 2022-06-21 | Luxembourg Inst Science & Tech List | Medium for in vitro transportation and storage of cells |
| WO2023018649A1 (en) * | 2021-08-10 | 2023-02-16 | Bayer Healthcare Llc | Liquid formulations comprising alginic acid, pectin, and carrageenan and methods of using thereof for gastric and gastroesophageal disorders |
| WO2023018661A1 (en) * | 2021-08-10 | 2023-02-16 | Bayer Healthcare Llc | Liquid formulations comprising alginic acid, pectin, and carrageenan and methods of using thereof |
| EP4162928A1 (en) * | 2021-10-05 | 2023-04-12 | Cosmo Technologies Ltd. | Rifamycin for the treatment of pouchitis, with an in-situ gelling formulation |
| EP4412588A1 (en) * | 2021-10-05 | 2024-08-14 | Cosmo Technologies Ltd | An in-situ gelling enema of rifamycin for treating pouchitis and distal ulcerative colitis |
| CN116510092A (zh) * | 2023-05-19 | 2023-08-01 | 西安富丞生物科技有限公司 | 一种辅助内镜手术的多功能温敏型水凝胶及其制备方法 |
| CN117362107B (zh) * | 2023-10-18 | 2025-04-18 | 山东农业大学 | 一种含有温敏嵌段共聚物开关的包膜控释肥及其制备方法 |
| MX2023012862A (es) * | 2023-10-27 | 2023-11-09 | Mar Mariana Guerrero | Composicion topica de agentes esclerosantes en portadores acuosos. |
| WO2025191166A1 (en) | 2024-03-15 | 2025-09-18 | Cosmo Technologies Ltd. | Cannula for rectal administration of an enema and compositions for use therewith |
| EP4616878A1 (en) | 2024-03-15 | 2025-09-17 | Cosmo Technologies Ltd. | Cannula for rectal administration of an enema and compositions for use therewith |
| WO2025210108A1 (en) * | 2024-04-03 | 2025-10-09 | Orocidin A/S | Composition for treatment of periodontal disease and related method |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5296236A (en) * | 1988-09-16 | 1994-03-22 | Recordati S.A., Chemical And Pharmaceutical Company | Controlled release therapeutic system for a liquid pharmaceutical formulations |
| US5143731A (en) * | 1990-08-07 | 1992-09-01 | Mediventures Incorporated | Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels |
| US5124151A (en) * | 1990-08-07 | 1992-06-23 | Mediventures Inc. | Drug delivery by injection with thermo-irreversible gels |
| US6280745B1 (en) * | 1997-12-23 | 2001-08-28 | Alliance Pharmaceutical Corp. | Methods and compositions for the delivery of pharmaceutical agents and/or the prevention of adhesions |
| KR100509119B1 (ko) | 1999-07-16 | 2005-08-18 | 주식회사 엘지생활건강 | 프로시아니딘 올리고머를 유효성분으로 하는 약제 |
| JP2006225398A (ja) | 2002-04-01 | 2006-08-31 | Kaken Pharmaceut Co Ltd | 塩基性線維芽細胞増殖因子含有歯科用粘稠製剤 |
| CN1794980A (zh) * | 2003-03-24 | 2006-06-28 | 生物领域医疗公司 | 利用逆向热敏聚合物的暂时栓塞 |
| CN101065385A (zh) * | 2004-07-22 | 2007-10-31 | 坎布里制药公司 | 治疗微生物感染的利福霉素衍生物 |
| CN101137369A (zh) * | 2005-02-09 | 2008-03-05 | 马库赛特公司 | 用于眼治疗的制剂 |
| WO2009023877A2 (en) * | 2007-08-16 | 2009-02-19 | Macusight, Inc. | Formulations for treatment of ocular diseases or conditions |
| WO2009090558A2 (en) * | 2008-01-14 | 2009-07-23 | Foamix Ltd. | Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses |
| KR101101321B1 (ko) | 2008-11-03 | 2012-01-02 | 주식회사 엠씨티티 | 상처 치유를 위한 하이드로 겔 형태의 세포전달용 비히클 및 그 제조방법 |
| EP2694113A4 (en) | 2011-04-01 | 2014-11-12 | Univ Florida | HEAT-SENSITIVE MUCOADHESIVE OR DERMOADHESIVE PENETRATION-IMPROVING FORMULATIONS FOR THE TOPICAL ADMINISTRATION OF THERAPEUTICS |
| PT2814495T (pt) * | 2012-02-13 | 2021-08-19 | Santarus Inc | Método de tratamento de doenças intestinais que apresentem pelo menos um componente inflamatório |
| FR2994844B1 (fr) * | 2012-08-31 | 2015-01-02 | Assist Publ Hopitaux De Paris | Formulation gelifiante a base de ketamine |
| WO2016161537A1 (en) * | 2015-04-08 | 2016-10-13 | Maxinase Life Sciences Limited | Bioadhesive compositions for intranasal administration of granistron |
| KR102123365B1 (ko) * | 2015-07-28 | 2020-06-16 | 바이옴 테라퓨틱스 리미티드 | 항박테리아 치료제 및 예방제 |
| EP3173067B1 (en) | 2015-11-16 | 2018-11-14 | Istanbul Universitesi Rektorlugu | Mucoadhesive buccal in situ gel formulation |
-
2017
- 2017-12-22 EP EP17210119.8A patent/EP3501496A1/en not_active Withdrawn
-
2018
- 2018-12-20 EP EP25160902.0A patent/EP4574173A1/en active Pending
- 2018-12-20 ES ES18825704T patent/ES3031471T3/es active Active
- 2018-12-20 KR KR1020207018372A patent/KR20200103012A/ko active Pending
- 2018-12-20 FI FIEP18825704.2T patent/FI3727453T3/fi active
- 2018-12-20 CN CN201880082774.XA patent/CN111511352A/zh active Pending
- 2018-12-20 MX MX2020006664A patent/MX2020006664A/es unknown
- 2018-12-20 EP EP18825704.2A patent/EP3727453B1/en active Active
- 2018-12-20 PL PL18825704.2T patent/PL3727453T3/pl unknown
- 2018-12-20 US US16/956,872 patent/US12011483B2/en active Active
- 2018-12-20 RU RU2020124103A patent/RU2020124103A/ru unknown
- 2018-12-20 BR BR112020012519-9A patent/BR112020012519A2/pt unknown
- 2018-12-20 DK DK18825704.2T patent/DK3727453T3/da active
- 2018-12-20 CA CA3081633A patent/CA3081633A1/en active Pending
- 2018-12-20 JP JP2020534389A patent/JP7494116B2/ja active Active
- 2018-12-20 WO PCT/EP2018/086424 patent/WO2019122253A1/en not_active Ceased
- 2018-12-20 KR KR1020247028154A patent/KR20240133770A/ko not_active Ceased
-
2020
- 2020-07-13 MX MX2023007117A patent/MX2023007117A/es unknown
-
2024
- 2024-05-17 US US18/667,420 patent/US20240299551A1/en active Pending
- 2024-05-22 JP JP2024083518A patent/JP2024100934A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| FI3727453T3 (fi) | 2025-07-07 |
| EP3727453A1 (en) | 2020-10-28 |
| US12011483B2 (en) | 2024-06-18 |
| KR20200103012A (ko) | 2020-09-01 |
| EP3501496A1 (en) | 2019-06-26 |
| RU2020124103A (ru) | 2022-01-24 |
| DK3727453T3 (da) | 2025-06-23 |
| EP3727453B1 (en) | 2025-04-16 |
| BR112020012519A2 (pt) | 2021-02-23 |
| ES3031471T3 (en) | 2025-07-09 |
| JP7494116B2 (ja) | 2024-06-03 |
| CA3081633A1 (en) | 2019-06-27 |
| KR20240133770A (ko) | 2024-09-04 |
| MX2020006664A (es) | 2020-08-31 |
| WO2019122253A1 (en) | 2019-06-27 |
| JP2024100934A (ja) | 2024-07-26 |
| US20240299551A1 (en) | 2024-09-12 |
| RU2020124103A3 (pl) | 2022-01-24 |
| JP2021506913A (ja) | 2021-02-22 |
| US20210154300A1 (en) | 2021-05-27 |
| EP4574173A1 (en) | 2025-06-25 |
| CN111511352A (zh) | 2020-08-07 |
| MX2023007117A (es) | 2023-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL3727453T3 (pl) | Ciekła kompozycja jako nośnik | |
| DK3394033T3 (da) | Heterocykliske forbindelser som immunmodulatorer | |
| LT3283080T (lt) | C9orf72 ekspresijos moduliavimo kompozicijos | |
| HUE041976T2 (hu) | Cisztein-módosított ellenanyagokat tartalmazó konjugált vegyületek | |
| DK3294713T3 (da) | Substituerede tetrahydroquinolinonforbindelser som ror-gamma-modulatorer | |
| DK3131902T3 (da) | Forbindelser som ROR-gamma-modulatorer | |
| DK3416996T3 (da) | Hærdelig sammensætning | |
| EP3609871A4 (en) | ARYL CYCLOPROPYL-AMINO-ISOQUINOLINYL AMIDE COMPOUNDS | |
| DK3496551T3 (da) | Flydende allulosesammensætning | |
| DK3612519T3 (da) | Phenyl-2-hydroxy-acetylamino-2-methyl-phenyl forbindelser | |
| DK3370804T3 (da) | Patronbæreranordning | |
| DK3369670T3 (da) | Indlejret containerbærer | |
| DK3221414T3 (da) | Farveskiftende klæbesammensætning | |
| DK3158847T3 (da) | Bæreanordning | |
| PL3364770T3 (pl) | Kompozycja zawierająca fazę olejową | |
| DK3284976T3 (da) | Planetbærer | |
| DK3672941T3 (da) | Pyridylpyridonforbindelser | |
| EP4074283C0 (en) | SUPPORT FOR SACROCOLPOPEXY | |
| EP3724416C0 (fr) | Lisse à parties détachables | |
| DK3672962T3 (da) | Morpholinylpyridonforbindelser | |
| FR3022915B1 (fr) | Composition adhesive de scellage | |
| EP3705374A4 (en) | PROMOTERS | |
| HUE056928T2 (hu) | Új vegyületek | |
| DK3441063T3 (da) | Flydende thioureylensammensætninger | |
| FR3024157B1 (fr) | Composition lubrifiante comprenant un compose anti-cliquetis |